Publications by authors named "S Lamure"

Claim this Profile
O
Ocular Involvement as First Sign of Recurrence of Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma (MEITL).
Maxime Nhari, Sylvain Lamure, Yann Guillermin, Lucas Sejournet, Laurent Kodjikian

Ocul Immunol Inflamm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large B-cell lymphoma: The LYSA pragmatic guidelines.
Pierre Sesques, Guillaume Manson, Sydney Dubois, Francois Xavier Gros, Gabriel Brisou, Sylvain Lamure

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine.
Sylvain Lamure, Houria Hendel Chavez, Marie-Ghislaine de Goër de Herve, Luc-Matthieu Fornecker, Bernard Drenou

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry.
B Ferment, J Lambert, D Caillot, I Lafon, L Karlin, S Lamure

Br J Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.
Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Sylvain Lamure

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis